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Structural features of halophilicity derived from the crystal
structure of dihydrofolate reductase from the Dead Sea
halophilic archaeon, Haloferax volcanii
Ursula Pieper1, Geeta Kapadia1, Moshe Mevarech2 and Osnat Herzberg1*
Background: The proteins of halophilic archaea require high salt
concentrations both for stability and for activity, whereas they denature at low
ionic strength. The structural basis for this phenomenon is not yet well
understood. The crystal structure of dihydrofolate reductase (DHFR) from
Haloferax volcanii (hv-DHFR) reported here provides the third example of a
structure of a protein from a halophilic organism. The enzyme is considered
moderately halophilic, as it retains activity and secondary structure at
monovalent salt concentrations as low as 0.5 M.
Results: The crystal structure of hv-DHFR has been determined at 2.6 Å
resolution and reveals the same overall fold as that of other DHFRs. The
structure is in the apo state, with an open conformation of the active-site gully
different from the open conformation seen in other DHFR structures. The
unique feature of hv-DHFR is a shift of the α helix encompassing residues
46–51 and an accompanied altered conformation of the ensuing loop relative to
other DHFRs. Analysis of the charge distribution, amino acid composition,
packing and hydrogen-bonding pattern in hv-DHFR and its non-halophilic
homologs has been performed. 
Conclusions: The moderately halophilic behavior of hv-DHFR is consistent
with the lack of striking structural features expected to occur in extremely
halophilic proteins. The most notable feature of halophilicity is the presence of
clusters of non-interacting negatively charged residues. Such clusters are
associated with unfavorable electrostatic energy at low salt concentrations, and
may account for the instability of hv-DHFR at salt concentrations lower than
0.5 M. With respect to catalysis, the open conformation seen here is indicative
of a conformational transition not reported previously. The impact of this
conformation on function and/or halophilicity is unknown.
Introduction
Microorganisms that are adapted to living under extreme
saline conditions have been found in many hypersaline
environments, such as in the Dead Sea and in the Great
Salt Lake, Utah. In order to survive at high salt concentra-
tions these microorganisms have to maintain an osmotic
balance with their external environment. The halophilic
archaea cope with the external salinity by accumulating
KCl intracellularly to concentrations up to 4 M [1]. 
Most of the enzymes of halobacteria are active and stable
at high salt concentrations and lose activity at salt con-
centrations lower than 2 M [2–3]. Sequence comparisons
show that, in general, the halophilic proteins contain an
excess of negatively charged amino acids over positively
charged amino acids, and the number of negatively charged
amino acid residues is higher than that in their non-
halophilic homologs. The additional negative charges are
located mostly on the protein surface, presumably helping
to stabilize the protein molecule by competing with the
salt for hydration [2]. It has also been proposed that
hydrophobic interactions play an important role in the
ability of these proteins to cope with the salt stress in a
hypersaline environment [4–6]. 
The crystal structures of two enzymes from the halophilic
archaeon Haloarcula marismortui have been reported: malate
dehydrogenase (MDH) and 2Fe–2S ferredoxin. Based
on the analysis of the structure of halophilic MDH, an
enzyme that functions at NaCl concentrations higher than
2 M, it was concluded that an increase in the number of
salt bridges compared with the non-halophilic homologs
enhances stability at high salt concentrations [7]. Enrich-
ments of salt bridges were not found, however, in the
crystal structure of 2Fe–2S ferredoxin from the same
archaeon [8]. Instead, the entire surface of the ferredoxin
protein is coated with acidic residues, with the exception of
the active site. In addition, in this protein two amphipathic
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helices enriched with negatively charged residues are
inserted near the N terminus and may confer further sta-
bility. In contrast to MDH, the ferredoxin is considered
only a moderately halophilic protein, because it is stable
and functional down to salt concentrations of 0.4 M [9]. 
Dihydrofolate reductase from Haloferax volcanii (hv-
DHFR) is a moderately halophilic enzyme, being stable
and active at a concentration of NaCl or KCl higher than
0.5 M. A rapid loss of structure and activity is observed
at lower salt concentrations [9]. The long term stability
of the enzyme under these conditions has not been
determined. Statistical analysis of the amino acid compo-
sition of 22 DHFRs showed that the increase in negative
charge in the halophilic enzyme is insignificant com-
pared with other exchanges of amino acids within the
sample of 22 sequences [10].
Functionally, DHFR is an essential enzyme that cat-
alyzes the NADPH-linked reduction of 7,8-dihydrofolate
to 5,6,7,8-tetrahydrofolate. This reaction is necessary to
regenerate tetrahydrofolate following the production of
thymidylate, one of the DNA building units. Thus, DHFR
is coupled to cell division, and both DHFR and thymidy-
late synthase are target enzymes in cancer chemotherapy.
DHFR is inhibited by antineoplastics, such as metho-
trexate. Moreover, species-dependent differences in the
enzyme’s sensitivity to inhibitors are responsible for the
efficacy of the antibacterial compound trimethoprim and
the antimalarial compound pyrimethamine.
Recently, a new Haloferax volcanii gene was isolated that
codes for a second DHFR (M Ortenberg and M Mevarech,
unpublished data). The lack of cross-hybridization between
the two DHFR genes, and the level of amino acid
sequence identity (~40%), suggest that one of the genes
may have been obtained by lateral gene transfer. The
physiological role of each of the two DHFRs is currently
under investigations.
We report here the crystal structure of (hv-DHFR), the
first protein structure to be determined from Haloferax
volcanii. DHFR is an excellent subject for comparative
structural studies, because the three-dimensional struc-
tures of this enzyme have been obtained at high resolution
from Escherichia coli [11–12], Lactobacillus casei [11–13],
Pneumocystis carinii [14], chicken [15], mouse [16] and
human [17]. Despite the low level of sequence identity,
the three-dimensional structures of DHFR from these dif-
ferent organisms are similar. In this paper, we discuss the
structural differences between hv-DHFR and its non-
halophilic counterparts. The findings are compared with
the information available for two other examples of struc-
tures of halophilic proteins. In addition, the hv-DHFR
structure reveals a novel conformational transition that
may accompany substrate binding. 
Results and discussion
Structure determination
The automated sequence alignment procedures FASTA
[18] and MPsrch [19] show that the highest level of amino
acid sequence identity between hv-DHFR and other
DHFRs of known structure is with the enzyme from
E. coli (32% identity; Table 1). At that level of homology,
the Molecular Replacement (MR) method seemed suit-
able for structure determination. A number of structures of
DHFR from E. coli (ec-DHFR) and from other organisms
were available as search models in the Protein Data Bank
[20]. In addition, a model of the hv-DHFR, developed
using comparative modeling methods, was available [21].
Nevertheless, attempts to use each of these structures in
searches that employed various MR computer programs
were unsuccessful. Ultimately, following the experience
of Leahy et al. [22], the structure was determined using a
composite model of seven different coordinate sets super-
positioned on each other (Table 1). All sidechains were
included in the model and each molecule was given equal
weight (Figure 1). 
Using the MR program AMoRe [23], the self-rotation func-
tion confirmed that there are two independent molecules
in the asymmetric unit, consistent with the density mea-
surements of the crystals and calculation of cell content.
The cross-rotation function did not show any significant
peak higher than the background. A translation search was
performed using the 25 highest peaks of the rotation func-
tion, yielding two solutions with correlation coefficients
above the background. A translation search with the mol-
ecules led to a significantly higher correlation coefficient.
The correct solution was confirmed by a rigid-body refine-
ment that increased the correlation coefficient further and
reduced the R value (R = Σh ||Fo| – |Fc|| ⁄ Σh |Fo|, where
|Fo| and |Fc| are the observed and calculated structure-
factor amplitudes, respectively).
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Table 1
DHFR coordinates used in molecular replacement.
PDB Sequence
entry code identity
with hv-DHFR (%)
DHFR from E. coli 32
complex with methotrexate 4dfr
holoenzyme 5dfr
complex with NADP 6dfr
complex with folate and NADP 7dfr
DHFR from chicken liver 8dfr 25
complex with NAD or NADP
DHFR from L. casei 3dfr 23
complex with NADPH
and methotrexate
hv-DHFR (Fidelis’ model) 100
To assess the importance of using a multimolecule search
model, several tests were carried out with single-molecule
search models, and with a combined model comprising
only the ec-DHFR structures. The results are summarized
in Table 2, and show that the correct solution could also
be identified for the combined ec-DHFR model and for
two of the ec-DHFR structures taken separately. However,
the discrimination between the right solution and the next
highest incorrect solution is poor, in particular for the
single-molecule search models.
A structural sequence alignment (Figure 2) shows that the
sequence identity between hv-DHFR and ec-DHFR is
actually 28%, lower than predicted by the sequence align-
ment. This level of homology may be marginal for current
MR methods, explaining the difficulties encountered in
applying the method and later during the process of struc-
ture refinement.
Refinement
After an initial simulated-annealing cycle, using the struc-
ture of hv-DHFR modeled by Fidelis as the starting model,
approximately 70% of the polypeptide chain was associated
with well defined electron density. Building of the remain-
ing chain involved numerous reiterations of the refinement
cycles. These reiterations were combined with the omission
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Figure 1
Superposition of the search models used in
the molecular replacement (yellow) with the
refined structure of hv-DHFR (blue). The
figure shows (a) an all-atom representation
and (b) a Cα trace. Residues 43–65
correspond to a region with one of the largest
deviations between the search models and
the actual structure; some of these residues
are labeled. (The figure was generated with
the program RASTER3D [47,48].)
Table 2
Molecular replacement results.
Combined search Combined search 3dfr 4dfr 7dfr hv-DHFR
model from seven model using five (molecule B) model
coordinate sets E. coli coordinate
sets
Correct rotation
function solution 3rd and 13th peak 6th and 9th peak 11th peak 7th and 16th peak 7th and 22nd peak 2nd peak
Correct translation c = 18.9/R = 55.0 c = 18.1/R = 54.4 No correct c = 15.8/R = 54.1 c = 16.3/R = 55.3 No correct
function solution c = 18.7/R = 54.6 c = 17.9/R = 54.6 solution c = 16.9/R = 55.0 c = 17.0/R = 56.0 solution
(one molecule)* (c = 15.4/R = 55.9) (c = 15.0/R = 56.3) (c = 15.6/R = 55.2) c = 14.7/R = 56.3)
Correct translation c = 31.1/R = 48.5 c = 28.4/R = 49.2 c = 22.1/R = 51.5 c = 24.4/R = 50.3
function solution (c = 21.0/R = 51.5) (c = 20.6/R = 51.3) (c = 17.1/R = 52.7) (c = 18.7/R = 51.9)
(two molecules)*
Rigid-body refinement* c = 45.7/R = 43.6 c = 42.9/R = 44.2 c = 38.6/R = 45.7 c = 46.3/R = 44.4
(c = 35.9/R = 48.5) (c = 36.5/R = 46.7) (c = 36.4/R = 46.9) (c = 44.3/R = 46.8)
*c = correlation coefficient (%); R = R value (%). The value in parentheses indicates the next highest incorrect peak. No correct rotation function
solution could be found for single models of 5dfr, 6dfr, 8dfr and the other molecule in the asymmetric unit of 4dfr. PDB codes are as defined in
Table 1.
of segments of structure that required major adjustments
because of large differences between their actual conforma-
tion and the conformations of the respective segments in
any of the search models; this is illustrated in Figure 1 for
the α helix and loop regions comprising residues 43 to 58.
When the process was completed, the quality of the elec-
tron-density map was very good. The final R value is 0.184
for all data between 7.0–2.6 Å for which F > 2σ(F), and
0.209 for all data without amplitude cut-off.
The model includes the two molecules in the asymmetric
unit, termed A and B. Molecule A includes all but the
first residue and the C-terminal 159–162 residues. These
residues were associated with regions of weak electron
density, indicative of disorder. For molecule B, all but
residues 1, 123–125, and 160–162 are included. The model
includes three phosphate ions and 80 water molecules. The
root mean square (rms) deviations from ideal bond length
and bond angle values of the standard geometry compiled
by Engh and Huber [24] are 0.013 Å and 3.2°, respectively.
The mainchain conformations of two amino acid residues
(Asp18B and Ala60A, where A and B refer to the monomer
of the asymmetric unit) are sterically strained [25]. As with
all other known DHFR structures, the peptide bond
between Gly101 and Gly102 is cis (except where speci-
fied otherwise, the numbering scheme is based on the hv-
DHFR sequence; Figure 2). Superposition of the Cα
atoms of the two monomers in the asymmetric unit
results in an rms deviation of 0.6 Å, indicating that the
structure of the two molecules is very similar. Their
average crystallographic temperature factor values are
28.7 Å2 and 23.1 Å2, for molecules A and B, respectively.
Overall structure
hv-DHFR folds into an eight-stranded β sheet consisting
of seven parallel strands and a single C-terminal anti-
parallel strand (Figure 2). Four α helices pack against the
β sheet, two on each side. The fourth α helix ends with
three residues forming a 310 helix. The fold of hv-DHFR
is closer to that of the DHFRs of prokaryotic origin (e.g.
E. coli and L. casei) than to those from eukaryotic organ-
isms. The region of largest difference corresponds to the
α2 helix and the ensuing loop region, as shown in
Figure 1. Another notable difference is the deletion of six
residues in an extended loop region between β strands β7
and β8 of hv-DHFR compared with ec-DHFR. Conse-
quently, the loop forms a type II open tight turn. 
The L21 loop
The various crystal structures of DHFR that have been
reported have shown that ligand binding to DHFR is
accompanied by loop and domain motion. Three differ-
ent conformations, closed, open and occluded, have been
identified in ec-DHFR at different states of the catalytic
cycle. The conformational changes mainly affect the loop
comprising amino acid residues 13–20, termed the M20
loop [26]. The structures suggest that the M20 loop is
predominately closed over the reactants in the holo-
enzyme, Michaelis, and transition-state complexes. During
the remainder of the reaction cycle, when nicotinamide is
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Structure
The sequence and fold of DHFR from H. volcanii. (a) Secondary
structure scheme and a structural alignment of the amino acid
sequences of hv-DHFR with DHFR from E. coli (4dfr), L. casei (3dfr),
and chicken liver (8dfr). The invariant residues are highlighted in red
and conserved residues in the bacterial DHFRs are highlighted in blue.
The secondary structure according to Kabsch and Sander [49], as
defined in hv-DHFR, is indicated above the sequence by arrows
(β strands) and rods (α helices). Residue numbers follow the hv-DHFR
sequence. (b) The overall fold of DHFR from H. volcanii (the
phosphate ions found in the structure are shown in stick
representation). Helices are shown in red and β strands in green. (The
ribbon representation was generated with the programs MOLSCRIPT
and RASTER3D [47,48,50].)
not bound, the loop protrudes into the nicotinamide–ribose
binding pocket. Upon changing from the closed to the
occluded conformation, the central portion of the loop
rearranges from a β-hairpin loop type III′ to a 310 helix
through an intermediate open conformation, which allows
the nicotinamide–ribose into or out of its binding pocket. It
has been proposed that the conformational changes play a
role in proton transfer and transition-state stabilization [26].
The structure of hv-DHFR reported here represents the
apo state of the enzyme with phosphate ions bound in the
nicotinamide-binding site. The conformation of the loop
analogous to M20, L21, is very similar to that of the closed
conformation in ec-DHFR, although residues 17–20 form
a type I′ β-hairpin loop instead of the type III′ turn
observed in the closed conformation of ec-DHFR. The
L21 loop exhibits some of the highest crystallographic
temperature factors in the structure and in molecule B the
sidechain of Asp18 is disordered, indicating possible con-
formational flexibility. Figure 3 shows a superposition of
the Cα atoms of hv-DHFR with those of ec-DHFR in both
the occluded and closed states. Despite the so-called
closed conformation of the L21 loop in hv-DHFR, access
to the active site is not blocked. The α2 helix is shifted by
approximately 2.3 Å compared with the respective helix in
ec-DHFR, so that nicotinamide–ribose can diffuse into the
binding pocket (Figures 3 and 4).
The nucleotide-binding site
The electrostatic environment at the nucleotide-binding
site is similar in all known DHFR structures. In general,
the adenine moiety forms only van der Waals and
hydrophobic interactions with the protein. One exception
to this is in ec-DHFR, where an additional interaction
with the sidechain amide group of Gln102 occurs. Instead
of a glutamine residue, hv-DHFR contains a leucine in
this position, Leu108, the sidechain of which cannot be
involved in an electrostatic interaction. 
In all DHFR structures, a positively charged pocket is
formed to accommodate the phosphate groups of the
nucleotide. Although the structure of hv-DHFR does not
contain the nucleotide, two phosphate ions were identi-
fied in molecule B at positions were the phosphate groups
of NADPH are expected to bind (Figure 5a). Molecule A
contains only one phosphate ion, and the second site is
occupied by what was interpreted in the electron density
as a water molecule. The cis peptide bond between two
invariant glycine residues, which is common to all known
DHFR structures, is also present in hv-DHFR (between
Gly101 and Gly102). A hydrogen bond is formed between
the mainchain amide group of Gly102 and one of the
phosphate ions in molecule B, or a water molecule in mol-
ecule A. This interaction is equivalent to the interaction
seen in all the structures of the NADP-bound forms of
DHFR between the amide group of the cis peptide bond
and the phosphoryl group of the nucleotide.
The substrate-binding site
Crystallographic studies of complexes of ec-DHFR with
either the inhibitor methotrexate [11] or the substrate
folate [27] have shown that these structurally related
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Figure 3
Superposition of the Cα trace of hv-DHFR
(solid line), ec-DHFR in the closed
conformation (long dashes; PDB entry code
1rx9) and ec-DHFR in the occluded
conformation (short dashes; PDB entry code
1rx5). Every tenth residue of hv-DHFR is
labeled. 140
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Structure
compounds bind in a deep hydrophobic cleft which
bisects the DHFR molecule and contains a single polar
residue, Asp27. Although hv-DHFR was crystallized in
the presence of methotrexate, inhibitor binding could not
be accounted for in the electron-density map. In fact,
superposition of the hv-DHFR and the methotrexate-
bound ec-DHFR (PDB entry code 4dfr) shows that some
of the sidechains of residues located on the α1 helix block
methotrexate access to the hv-DHFR cleft (Figure 5b).
Key amino acid residues involved in substrate binding are
either conserved or replaced conservatively in hv-DHFR.
Some of these residues maintain the same conformation as
in other DHFRs of known structure, but there are also
notable differences. In the binding site of the pteridine
moiety, the catalytic residue Asp29 (Asp27 in ec-DHFR)
exhibits the same conformation as in all other structures.
Ser119 in hv-DHFR is equivalent to a threonine residue in
the other DHFRs (Thr113 in ec-DHFR). The hydroxyl
group of this threonine residue is hydrogen bonded to the
catalytic aspartate in the methotrexate-bound structures,
and is bridged to the 2-amino group of the pteridine
moiety via a water molecule. This water molecule is
present in all previously determined DHFR structures,
independent of the state of substrate binding, but is not
present in hv-DHFR. Furthermore, a second bridging
water molecule is hydrogen bonded to Asp27 and Trp21
and to the substrate/inhibitor in the E. coli enzyme. This
water molecule is also missing in the current hv-DHFR
structure. The absent water molecules may just reflect the
limited resolution of the data (2.6 Å), thus the functional
significance of this finding is unclear.
Another key interaction of the pteridine moiety is formed
between the 4-amino group of methotrexate and two
mainchain carbonyl oxygen atoms in both the E. coli and
L. casei DHFR (lc-DHFR) structures. The analogous inter-
actions in hv-DHFR would involve the carbonyl groups of
Val6 and Ile100. These are oriented appropriately for
binding even though the substrate-binding site is unoccu-
pied. In contrast, the sidechain of Tyr33 (analogous to a
phenylalanine that forms an aromatic–aromatic interaction
with the pteridine ring in the other DHFR structures)
blocks access to the pocket (Figure 5b). A slight shift of
the α1 helix of hv-DHFR compared with the respective
helix in ec-DHFR induces the conformation that prevents
binding. Assuming that the binding mode of the pteridine
moiety of methotrexate in hv-DHFR is the same as that
seen in ec-DHFR, the α1 helix and the sidechain of Tyr33
must undergo a conformational transition to accommodate
the methotrexate.
The binding site for the benzoylcarbonyl-L-glutamate-α-
carboxylate moiety of methotrexate is blocked in the hv-
DHFR structure by the sidechain of Arg34 (Figure 5b).
Another protein segment of hv-DHFR that should contact
80 Structure 1998, Vol 6 No 1
Figure 4
A comparison of the molecular surfaces of
halophilic and non-halophilic DHFRs. (a)
Representation of the molecular surface of hv-
DHFR and (b) ec-DHFR in the closed
conformation (PDB entry code 1rx9). The
colors highlight the electrostatic potential as
calculated by the program GRASP [33] with
negative potential in red and positive potential
in blue. The orientation is the same as in
Figure 3, with the C terminus of the
polypeptide chain at the top of the figure. The
figure illustrates that whilst hv-DHFR exhibits
an open conformation the L21 loop of this
protein adopts the same closed conformation
as that of the M20 loop in the closed
conformational state of ec-DHFR. For each
molecule, the left image corresponds to the
surface where the active site is located and
the right image corresponds to the opposite
face.
this part of methotrexate comprises residues 50–59. This
segment adopts a drastically different conformation to
that observed in either the methotrexate-bound or
unbound ec-DHFR structures and in the methotrexate-
bound lc-DHFR. Although the 50–59 segment of hv-
DHFR does not block access to methotrexate, it carries
Asp55 which is oriented towards the position where the
glutamate moiety of methotrexate should bind, by
analogy to ec-DHFR and lc-DHFR. To avoid repulsive
charge interactions, Asp55 must change conformation,
and this may be accompanied by global changes in the
50–59 segment. 
It is interesting to note that the arginine residue that inter-
acts with the α-carboxylate group of methotrexate in the
known structures (Arg57 in ec-DHFR) is replaced by a
serine in hv-DHFR. Only Arg34 in hv-DHFR could form
favorable electrostatic interaction with the α-carboxylate
group of methotrexate (upon conformational adjustments).
However, Arg34 is structurally equivalent to Arg32/Lys32
in ec-/lc-DHFRs, residues that do not form close inter-
actions with methotrexate. 
The carboxylate group of Asp55 in hv-DHFR is oriented
towards the expected position of the negatively charged
groups of methotrexate, an energetically unfavorable ori-
entation for binding. Asp55 and Asp54 constitute a unique
insertion in the sequence of hv-DHFR compared with
other DHFRs, and may be responsible in part for the very
different conformation of the 50–59 peptide. On the oppo-
site side of the substrate cavity (Figure 5b), two lysine
residues of hv-DHFR, Lys30 and Lys31, may counter the
electrostatic effect of the two aspartate residues on binding.
Single- and double-mutant enzymes have been produced,
in which each of the lysine residues was replaced by a
hydrophobic residue, resulting in a comparable increase in
kcat and Km [28]. The increase in the Km values may be
attributed to the elimination of the positive charges which
compensate for the unfavorable electrostatic contribution
of Asp54 and Asp55 to binding.
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Figure 5
The binding sites of hv-DHFR. (a) Stereo
representation of the nucleotide-binding site
in hv-DHFR. Only the Cα trace is shown,
except for residues Gly101–Gly102 where all
mainchain atoms are shown to highlight the
nonproline cis peptide bond. An NADP
molecule is modeled into the binding site
(dashed line), in the conformation found in ec-
DHFR; its phosphate groups were
superimposed onto the phosphate ions
identified in the crystal structure of hv-DHFR.
(b) Stereo representation of the substrate-
binding site in hv-DHFR superimposed with
the substrate-binding site of ec-DHFR
including the bound inhibitor methotrexate
(dashed line; PDB entry code 4dfr). Virtual
bonds between Cα atoms and an all-atom
sidechain representation are shown. Residues
of ec-DHFR are labeled in italics. 
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The above observations indicate that hv-DHFR may
utilize different loop and sidechain conformations for
binding the benzoylcarbonyl-L-glutamate-α-carboxylate
moiety, compared with those observed for ec-DHFR and
lc-DHFR. This proposal awaits experimental confirma-
tion, by determination of the structure of the methotrex-
ate- or folate-bound enzyme. Nevertheless, the blocked
access to the substrate-binding site implies that the enzyme
must undergo some conformational transition. In ec-
DHFR, the M20 loop alternates between conformations
that open or close the active-site depression depending on
the state of substrate or cofactor binding [26]. Although
the conformation of the equivalent loop in the structure of
hv-DHFR (the L21 loop) is similar to the closed confor-
mation seen in ec-DHFR, the L21 loop does not prevent
access to the active site (Figure 4) because the α2 helix
and the ensuing loop on the opposite side of the cleft
are shifted compared with the other DHFR structures
(Figure 3). Conformational adjustments within the α2
helix and loop provide an alternative mode of recognition
not realized in previously determined DHFR structures.
The α1 helix must also undergo conformational transition,
although not as extensive, in order to remove the steric
hinderance of the sidechains of Tyr33 and Arg34. 
hv-DHFR does not exhibit striking halophilic features
hv-DHFR is a moderately halophilic enzyme as it is active
and stable at monovalent salt concentrations as low as
0.5 M. Amino acid sequences of halophilic proteins typi-
cally show an enlarged number of negatively charged
residues compared with their non-halophilic homologs,
with glutamic acid residues being the most abundant of
these [2]. As carboxylate groups are capable of binding
more water molecules than other protein groups [29], it
has been proposed that these negatively charged residues
help to form a hydration shell and prevent the protein
from aggregation. At low salt concentrations, the high con-
centration of negatively charged residues is repulsive,
resulting in protein instability.
Consistent with the moderate halophilicity of hv-DHFR,
the polar, nonpolar, and charged amino acid contents are
similar to those of the DHFRs from E. coli and L. casei [10]
(Table 3). Although hv-DHFR contains a higher percent-
age of negatively charged amino acid residues (18.5%)
than its non-halophilic counterparts (ec-DHFR, 15.7%; lc-
DHFR, 13.6%), the difference is not statistically signifi-
cant [10]. Moreover, the number of negatively charged
residues is not uncommon in non-halophilic enzymes.
Examination of the charge distribution in the context of
the three-dimensional structure is required to gain better
understanding of the halophilic properties of the enzyme.
Another notable aspect of the amino acid sequence is that
while the percentage of positively charged residues is very
similar to that of the other two bacterial DHFRs of known
structure (9–10%), hv-DHFR exhibits an enrichment in
arginine residues compared with lysine residues. The
only two lysine residues in hv-DHFR are associated with
the substrate-binding site, as discussed above. The posi-
tive charge is more localized in lysine than in arginine.
An analysis of the distributions of water molecules
around well ordered amino acid residues in high resolu-
tion crystal structures [30] shows that arginine sidechains
tend to bind more water molecules than lysine sidechains.
The increased arginine to lysine ratio has also been
observed in other halophilic proteins [5]. A comparison
of MDH amino acid sequences [31] reveals an arginine
to lysine content of 8Arg : 25Lys and 8Arg : 21Lys for the
non-halophilic enzymes from pig mitochondria and E.
coli, respectively, whereas the Arg : Lys content for the
halophilic enzyme is 15Arg : 8Lys. A similar tendency is
observed in 2Fe–2S ferredoxin: the Arg : Lys ratios for
the non-halophilic Anabaena and halophilic enzymes are
0Arg : 4Lys and 3Arg:3Lys, respectively [8].
Previous comparative modeling led to the proposal that
the structure of hv-DHFR shows an asymmetrical charge
distribution over the protein surface, with positively
charged amino acids centered around the active site and
negative charges on the opposite side of the enzyme [9].
Indeed the crystal structure reveals that the highest con-
centration of positively charged residues are located in
the vicinity of the nucleotide- and substrate-binding sites,
whereas most of the remaining surface of the protein is
negatively charged. However, because the substrate and
cofactor are negatively charged compounds, the asym-
metrical charge distribution is of functional importance
and is also seen in the non-halophilic DHFRs, includ-
ing ec-DHFR [32]. Figure 4 illustrates the electrostatic
potential on the surfaces of hv-DHFR and ec-DHFR cal-
culated with the program GRASP [33]. The figure shows
that both proteins exhibit a highly negatively charged
surface. In addition to the accumulation of positive charges
in the active-site area, both proteins show positively
charged regions on the opposite side of the protein. In ec-
DHFR, a positively charged patch is centered around
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Table 3
Amino acid composition (%) of bacterial DHFRs with known
structure.
Amino acid residues H. volcanii E. coli L. casei
Nonpolar 44.4 45.9 43.8
Polar 27.8 28.9 32.1
Charged 27.7 25.1 24.1
Arg 13(8.0) 9(5.6) 8(4.9)
Lys 2(1.2) 6(3.8) 9(5.6)
Glu 16(9.9) 12(7.5) 7(4.3)
Asp 14(8.6) 13(8.2) 15(9.3)
residues Arg33, Lys38, Arg57 and Lys109. A positively
charged region, comprising Lys30, Lys31, Arg34, Arg36,
Arg115 and Arg157, is arranged differently in the
halophilic enzyme. The region extends from the active
site and forms a band between two negatively charged
regions. One of these regions, comprising residues 121–156,
contains a total of 11 negatively charged residues at the
bottom of the β sheet. The second negative potential
surface includes residues 2, 39–40, 83–95 and 114.
Whether these different modes of forming positively
charged regions have any implications for halophilic
behavior is presently unknown. 
The dominance of negatively charged residues within the
C-terminal segment of hv-DHFR is reminiscent of the
first 62 residues of halophilic ferredoxin, which are highly
enriched with carboxylate groups. The example of hv-
DHFR is not as dramatic, however, and this same feature
is also observed in the ec-DHFR sequence, where only
negatively charged residues are located between residues
110 and 157 (numbering according to ec-DHFR). 
The structure of MDH from H. marismortui, an extremely
halophilic protein [7], contains more salt bridges than its
non-halophilic homologs. It has been proposed that these
salt bridges, together with the excess of acidic over basic
residues, promote the stability of the protein at high salt
concentrations. The structure of the 2Fe–2S ferredoxin
from the same organism, that is only a moderately halophilic
enzyme [34], lacks this feature [8]. Similarly, there is no
significant increase in the number of salt bridge interac-
tions in hv-DHFR (Table 4). 
The crystal structure of halophilic 2Fe–2S ferredoxin
includes a similar number of water molecules to that of a
lysozyme structure determined at the same resolution
using data collected at the same temperature. The water
molecules in 2Fe–2S ferredoxin, however, form 40% more
hydrogen bonds than in the lysozyme structure. A reliable
analysis of solvent structure could not be made for hv-
DHFR, because the resolution of the diffraction data was
not sufficiently high. 
The potential to form negatively charged clusters is
expected to contribute most to the instability of halophilic
proteins at low salt concentrations. The previous predic-
tion of clusters made by Böhm and Jaenicke [9], based on
comparative modeling, can be now assessed critically in
the context of the experimentally determined structure of
hv-DHFR. Two clusters of three carboxylate groups were
highlighted by the authors. One proposed cluster, com-
prising Asp146, Glu148, and Glu154, is at error because
Glu154 is in fact quite remote from the other two residues,
with its sidechain oriented towards the opposite face of
the β sheet than Asp146 and Glu148. The error arose
from sequence misalignment compared with the structural
alignment, a common problem of comparative modeling.
Furthermore, Glu154 forms a salt bridge with Arg36,
countering the carboxylate charge. The second proposed
cluster, comprising Asp39, Asp40 and Glu95, is also inac-
curate because the sidechains of Asp39 and Asp40 are ori-
ented in the opposite direction to that of Glu95. The
predicted structure is based on sequence alignment which
considers Glu95 and a previous residue as an insertion
compared with most other DHFRs, including the E. coli
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Table 4
Statistics of the hydrogen-bonding pattern and salt bridges in hv-DHFR, ec-DHFR and lc-DHFR.
Data set Crystallization Intermolecular Intermolecular Intermolecular Intermolecular
(resolution) conditions salt bridges* hydrogen bonds* salt bridges* hydrogen bonds*
hv-DHFR 2.4 M phosphate
(2.6 Å) pH 8.0 2/12† 15/19† 8/6† 194/207†
0.5% PEG 1K
2 mM methotrexate
ec-DHFR 20% ethanol
4dfr (E. coli) 5 mM Ca acetate 8/7† 12/29† 6/6† 228/236†
(1.7 Å) His-HCl
pH 6.8
ec-DHFR 12% PEG 6K
7dfr (E. coli) 3% ethanol 0 36 7 207
(1.7 Å) phthalate buffer
pH unknown
lc-DHFR 55% NH4SO4
3dfr (L. casei) 10 mM Tris 2 14 9 239
(2.5 Å) pH 7.4
*The cut-off distance for salt bridges and hydrogen bonds was 3.5 Å. †The two numbers indicate the values for two independent molecules in the
asymmetric unit. The PDB codes are as defined in Table 1.
enzyme (see sequence alignment [9]). In fact, the struc-
tural alignment shows that there is no insertion in that
region, and the polypeptide chain follows closely the trace
of the ec-DHFR structure. In general, the hv-DHFR
crystal structure shows that the sidechains of clustered
negatively charged residues tend to orient as far away as
possible from each other.
Examples of regions of the hv-DHFR structure where
several negatively charge amino acid residues are located
in close proximity to each other but avoid direct electro-
static interactions are shown in Figure 6. Glu140, Asp142
and Glu154 of molecule B are located on two adjacent β
strands with a distance of 4–5 Å between their carboxylate
groups (Figure 6a). A water molecule is coordinated to the
central aspartate residue and the carboxylate group of
Glu154 forms salt bridges to two arginines (not shown),
reducing the repulsion between the negative charges. 
To counteract the excess negative charges, binding of
cations to the protein is expected [35]. Indeed, a number
of potassium ions have been identified in the crystal
structure of the halophilic ferredoxin [8]. The limited
resolution of the diffraction data of the hv-DHFR crys-
tals prevents identification of cations. Nevertheless, a
cluster of five negatively charged residues at the inter-
face of three neighboring molecules in the crystal has
been identified (Figure 6b). A fairly strong positive peak
in the difference electron-density map is located at the
center of the solvent region surrounded by the cluster;
the peak is located rather a long distance away from any
of the carboxylate groups. A water molecule was assigned
and refined at this position, although well ordered water
molecules are not expected at such a location. It is quite
possible that this peak represents a cation whose position
may be partially restricted because of the surrounding
negative charges. Long range restriction of ions around
proteins has been observed in accurate molecular dynamic
simulations performed in the context of the crystal of
Streptomyces griseus protease A [36]. 
Only two direct intramolecular carboxyl–carboxylate inter-
actions at a 3.5 Å cut-off distance occur in the structure of
hv-DHFR (Figure 7). Figure 7a shows the interaction
between Asp135 and Glu138 in molecule B, which also
involves a lysine residue of a neighboring molecule. The
lysine residue may mimic the role of a positively charged
ion in vivo in neutralizing the unfavorable interaction.
However, in molecule A, where no crystal contacts are
observed, the sidechain of Glu138 is disordered.
The second unfavorable interaction occurs between two
glutamic acid residues of neighboring molecules (Figure 7b).
There is no positively charged residue located in the
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Figure 6
Stereo representation of two clusters of
negatively charged residues in hv-DHFR.
Water molecules are depicted as black
spheres and hydrogen bonds as dashed lines. 
(a) Intramolecular cluster; (b) intermolecular
cluster at the interface of three molecules.
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vicinity. Carboxy–carboxylate interactions are associated
with an abnormally high pKa value of approximately 6, and
have been observed in other crystal structures (see for
example [37]). However, the DHFR crystals were obtained
at a much higher pH (pH 8). Although the electron density
associated with these residues is clear, the model of this
region should be regarded with low confidence. The crys-
tallographic temperature factors of the residues are high and
amino acid residues 123–125, preceding Glu126 of mol-
ecule B, are disordered.
The two adjacent aspartate residues, Asp54 and Asp55,
may be relevant to function. Although their sidechains
point in opposite directions in the apo state of the
enzyme, they may change orientation as the loop carrying
them undergoes conformational transitions during the
catalytic cycle. These two negatively charged residues
are a unique feature of halophilic DHFR, thus they may
play a role in linking the halophilic properties of the
enzyme to function. This hypothesis could be tested by
site-directed mutagenesis.
It has been suggested, that at high salt concentration
hydrophobic interactions predominate and the protein
molecules assume more tightly packed structures [6].
Therefore, the hydrogen bonding between amino acid
residues has been analyzed to obtain information about
the packing. The number of hydrogen bonds found in hv-
DHFR, two ec-DHFR structures and lc-DHFR is similar,
with no significant difference in the pattern (Table 4).
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Figure 7
Stereo representation of the
carboxy–carboxylate interactions in hv-DHFR.
The difference Fourier electron-density map is
shown together with the model. The
coefficients 2Fo–Fc and calculated phases
were used; the map is contoured at 1σ level.
(a) Intramolecular interaction between an
aspartate and a glutamate residue. (b)
Intermolecular glutamate–glutamate
interaction.
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The surface areas and the volumes of various DHFR
structures, calculated with the program GRASP and nor-
malized to the number of amino acid residues, are summa-
rized in Table 5. No significant trend is indicated from
these data that would confirm the above proposal.
Biological implications
The delicate balance between stabilizing and destabiliz-
ing interactions in proteins renders them marginally
stable. Proteins often respond to extreme changes in
temperature, hydrostatic pressure, pH and salinity by
unfolding, activity loss, and aggregation. Adaptation to
extreme environments involves changes in the amino
acid sequence that ensure the appropriate fold, substrate
binding and solubility of the protein molecule in aqueous
solution. The structural basis for adaptation to extreme
halophilic conditions is addressed in this study.
Many halophilic proteins contain excess negatively
charged amino acid residues in comparison with their
non-halophilic counterparts. The presence of these neg-
atively charged residues probably helps to solubilize
these proteins when the availability of water molecules
is restricted by high salt concentration. The amino acid
sequence of dihydrofolate reductase from the Dead Sea
archaeon Haloferax volcanii (hv-DHFR) is moderately
enriched with negatively charged residues relative to the
non-halophilic DHFRs. Nevertheless, evidence from the
study presented here raises the possibility that this may
not be an essential requirement for halophilicity. hv-
DHFR functions at monovalent ion concentrations as
low as 0.5 M, but its optimal activity is at 3–4 M. Recog-
nizing the fact that many non-halophilic proteins are
active at high salt concentrations, the question that is
addressed here is why halophilic proteins unfold and
loose activity at low salt concentrations. The structure
of hv-DHFR lacks the striking features previously
identified as characterizing halophilicity in ferredoxin
and malate dehydrogenase. Neither the hypernega-
tively charged domain of ferredoxin nor the internal
salt bridges of malate dehydrogenase occur in hv-
DHFR. There are, however, clusters of negative charges
on the surface of the molecule, which do not form close
interactions but may be relevant to the moderately
halophilic properties of the protein. These residues are
implicated in halophilicity because they are energeti-
cally repulsive at physiological pH unless they are
counteracted by cation binding.
The hv-DHFR structure provides new information
about the apo state of the enzyme, showing considerable
shifts of some loops and helical units compared with
other DHFRs of known structure. These shifts indicate
that the enzyme may undergo conformational transi-
tions upon substrate binding that are different from
those identified previously.
Materials and methods
Crystallization, data collection and data processing
DHFR from H. volcanii was over-produced by gene amplification in
response to the addition of trimethoprin to the bacterial growth media
[38]. The protein was purified as previously reported [39]. Crystals
were obtained using the hanging drop vapor diffusion method at room
temperature. The reservoir solution contained 2.4 M phosphate buffer
(pH 7.8–8.0), 0.25–0.5% polyethylene glycol (PEG) 1000 and 2 mM
methotrexate. Equal volumes of reservoir solution and 10 mg/ml protein
solution in 0.1 M phosphate buffer at pH 7.0 were mixed. Crystals
achieved their final size within two weeks. The crystals were mono-
clinic, belonging to the space group C2 (a = 70.9 Å, b = 59.5 Å,
c = 78.2 Å, β = 95.0°). Density measurements using the water satu-
rated xylene-bromobenzene gradient tube method [40] and the self-
rotation function using AMoRe [23] showed that there were two
crystallographically independent molecules in the asymmetric unit.
X-ray diffraction data to a resolution of 2.6 Å were collected at room
temperature on a Siemens 3-axis goniostat using a single crystal of
approximate dimensions of 0.2 × 0.2 × 0.3 mm3. Graphite monochro-
mated CuKα radiation was generated with a Rigaku RU200BH rotating
anode. The data were processed using the program suite XENGEN
[41]. A total of 10 496 unique reflections (98% complete set) were
collected at 2.55 Å resolution, with an Rmerge value of 0.073
(Rmerge = ΣhΣi| < I(h) > –I(h)i|/ΣhΣiI(h)i for equivalent reflections). The
data redundancy is 2.8, and the mean value of I/σ(I) is 18.2. At the
highest resolution shell between 2.71–2.55, the data is 88% complete
and the mean I/σ(I) is 2.4. The structure was solved by MR with the
program AMoRe [23] using a multimolecule search model as
described in the Results section. 
Refinement
Two molecules of the modeled structure of hv-DHFR [21] were posi-
tioned in the cell according to the MR solutions and were initially sub-
jected to X-PLOR simulated-annealing refinement in the temperature
range 3000K to 300K [42]. Data in the range 7.0–3.0 Å for which
F ≥ 2σ(F) were included. The R factor was 0.280 (Rfree = 0.380;
[43]). Approximately 70% of the initially refined model was consistent
with the electron-density map. The computer graphics program
TURBO-FRODO was used for model building [44]. Subsequent
positional refinement using noncrystallographic symmetry restraints
as implemented in X-PLOR and including only the 70% of the molecule
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Table 5
Surface area and volume in various DHFR structures.
Surface area (Å2)* Volume (Å3)*
hv-DHFR 44.1/44.2† 123.2/122.1†
3dfr (L. casei) 46.5 130.0
4dfr (E. coli) 44.1/44.7† 127.9/130.0†
5dfr (E. coli) 43.9 123.7
6dfr (E. coli) 42.8 123.5
7dfr (E. coli) 43.7 123.6
8dfr (chicken) 46.2 131.7
1dyr (P. carinii) 46.5 136.4
1dhf (human) 48.0/45.8† 132.3/136.4†
*The surface area and volume are normalized to the number of amino
acid residues. †The two values correspond to the two molecules in the
asymmetric unit. The PDB codes are provided.
evaluated as correct did not improve the quality of the map in regions
of missing amino acid residues. Gradual tracing of the remaining
residues involved an additional seven cycles of simulated annealing
and temperature-factor refinement at 2.6 Å resolution, followed by
noncrystallographic symmetry averaging using RAVE [45,46]. At this
stage the R factor was reduced to 0.220 (Rfree = 0.320). The quality
of subsequent electron-density maps enabled the addition of three
phosphate ions and 80 water molecules. Next, noncrystallographic
restraints were released and after further refinement the R factor was
reduced to 0.180 (Rfree = 0.300). Finally, a cycle of positional and
temperature-factor refinement was performed, adding the randomly
selected data previously used for the Rfree calculation and resulting in
an R factor value of 0.184 for data between 7.0–2.6 Å resolution for
which F ≥ 2σ(F). 
The crystals have been obtained from solutions containing methotrex-
ate, an inhibitor of DHFR. In addition, trimethoprim, another inhibitor of
DHFR, and NADPH were present during the expression of the protein.
Thus, the site of the cofactor and substrate binding were scrutinized for
binding of any of these compounds. Initially, residual electron density
was observed in both sites, but it was not extensive enough to account
for either methotrexate, trimethoprim, or NADPH. Moreover, both binding
sites are partially blocked as discussed above, supporting the interpre-
tation that this crystal structure represents the apo state of the enzyme.
Phosphate ions and water molecules fully account for the density in the
binding sites.
Accession numbers
The atomic coordinates have been deposited in the Brookhaven
Protein Data Bank (entry code 1dvr).
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